Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07264075 |
| Title | Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN (ILLUMINE) |
| Acronym | ILLUMINE |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Groupe Oncologie Radiotherapie Tete et Cou |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA |